The article Are LSD and r-MDMA the Future of Psychedelics? MindMed Says Yes was originally published on Microdose. On March 8th, MindMed (Nasdaq: MNMD,...
A clinical trial launched by Sunstone Therapies demonstrated the effectiveness of group therapy as part of psilocybin-assisted therapy for depression. The...
The article News You Might Have Missed: March 7th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The group hopes to advance research of psychedelics use in clinical settings. The post Congressional Psychedelics Caucus Relaunched appeared first on Green...
Industry leaders are exploring alternative IP strategies that can fuel creativity in psychedelic medicine. The post Do Psychedelics Demand an Innovative...
Clinical social worker Ashley Booth discusses how combining modalities like Hakomi and Internal Family Systems with psychedelic-assisted therapy help people...
The past year saw plummeting valuations for psychedelic companies, a late comeback for stock values, emerging methodical challenges in clinical trials,...
This week Auntie considers the challenges of understanding possible contraindications between psychedelics and prescribed medications, why not all high...
The proposal would allow Lucy to manufacture substances for Canada's harm reduction program. The post Psychedelic Medicines Company Requests Approval to...
Location, location, location is the key for psychedelic drugs that could treat mental illness by rapidly rebuilding connections between nerve cells. In...